Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Natalia Perdek"'
Autor:
Emma S. Chambers, Weigang Cai, Giulia Vivaldi, David A. Jolliffe, Natalia Perdek, Wenhao Li, Sian E. Faustini, Joseph M. Gibbons, Corinna Pade, Alex G. Richter, Anna K. Coussens, Adrian R. Martineau
Publikováno v:
npj Vaccines, Vol 9, Iss 1, Pp 1-9 (2024)
Abstract Vaccine development targeting SARS-CoV-2 in 2020 was of critical importance in reducing COVID-19 severity and mortality. In the U.K. during the initial roll-out most individuals either received two doses of Pfizer COVID-19 vaccine (BNT162b2)
Externí odkaz:
https://doaj.org/article/2bf8b9f303d3489cb53fdb91aa74388d
Autor:
Mohammad Talaei, Sian Faustini, Hayley Holt, David A. Jolliffe, Giulia Vivaldi, Matthew Greenig, Natalia Perdek, Sheena Maltby, Carola M. Bigogno, Jane Symons, Gwyneth A. Davies, Ronan A. Lyons, Christopher J. Griffiths, Frank Kee, Aziz Sheikh, Alex G. Richter, Seif O. Shaheen, Adrian R. Martineau
Publikováno v:
BMC Medicine, Vol 20, Iss 1, Pp 1-18 (2022)
Abstract Background Prospective population-based studies investigating multiple determinants of pre-vaccination antibody responses to SARS-CoV-2 are lacking. Methods We did a prospective population-based study in SARS-CoV-2 vaccine-naive UK adults re
Externí odkaz:
https://doaj.org/article/b7da12e1b2c54b6dafee73e239876df6
Autor:
David A. Jolliffe, Sian E. Faustini, Hayley Holt, Natalia Perdek, Sheena Maltby, Mohammad Talaei, Matthew Greenig, Giulia Vivaldi, Florence Tydeman, Jane Symons, Gwyneth A. Davies, Ronan A. Lyons, Christopher J. Griffiths, Frank Kee, Aziz Sheikh, Seif O. Shaheen, Alex G. Richter, Adrian R. Martineau
Publikováno v:
Vaccines, Vol 10, Iss 10, p 1601 (2022)
Antibody responses to SARS-CoV-2 vaccines vary for reasons that remain poorly understood. A range of sociodemographic, behavioural, clinical, pharmacologic and nutritional factors could explain these differences. To investigate this hypothesis, we te
Externí odkaz:
https://doaj.org/article/6ecab6ed88594c469e61463d03cf769b
Autor:
Giulia Vivaldi, David A Jolliffe, Sian Faustini, Adrian M Shields, Hayley Holt, Natalia Perdek, Mohammad Talaei, Florence Tydeman, Emma S Chambers, Weigang Cai, Wenhao Li, Joseph M Gibbons, Corinna Pade, Áine McKnight, Seif O Shaheen, Alex G Richter, Adrian R Martineau
Publikováno v:
The Journal of Infectious Diseases. 226:1903-1908
In this population-based cohort of 7538 adults, combined immunoglobulin (Ig) G, IgA, and IgM (IgG/A/M) anti-spike titers measured after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination were predictive of protection against bre
Autor:
David A Jolliffe, Hayley Holt, Matthew Greenig, Mohammad Talaei, Natalia Perdek, Paul Pfeffer, Giulia Vivaldi, Sheena Maltby, Jane Symons, Nicola L Barlow, Alexa Normandale, Rajvinder Garcha, Alex G Richter, Sian E Faustini, Christopher Orton, David Ford, Ronan A Lyons, Gwyneth A Davies, Frank Kee, Christopher J Griffiths, John Norrie, Aziz Sheikh, Seif O Shaheen, Clare Relton, Adrian R Martineau
Publikováno v:
Jolliffe, D A, Holt, H, Greenig, M, Talaei, M, Perdek, N, Pfeffer, P, Vivaldi, G, Maltby, S, Symons, J, Barlow, N L, Normandale, A, Garcha, R, Richter, A G, Faustini, S E, Orton, C, Ford, D, Lyons, R A, Davies, G A, Kee, F, Griffiths, C J, Norrie, J, Sheikh, A, Shaheen, S O, Relton, C & Martineau, A R 2022, ' Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and covid-19 : phase 3 randomised controlled trial (CORONAVIT) ', BMJ (Clinical research ed.), vol. 378, 071230, pp. e071230 . https://doi.org/10.1136/bmj-2022-071230
Jolliffe, D A, Holt, H, Greenig, M, Talaei, M, Perdek, N, Pfeffer, P, Vivaldi, G, Maltby, S, Symons, J, Barlow, N L, Normandale, A, Garcha, R, Richter, A G, Faustini, S E, Orton, C, Ford, D, Lyons, R A, Davies, G A, Kee, F, Griffiths, C J, Norrie, J, Sheikh, A, Shaheen, S O, Relton, C & Martineau, A R 2022, ' Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and covid-19: phase 3 randomised controlled trial (CORONAVIT) ', BMJ, vol. 378, e071230 . https://doi.org/10.1136/bmj-2022-071230
Jolliffe, D A, Holt, H, Greenig, M, Talaei, M, Perdek, N, Pfeffer, P, Vivaldi, G, Maltby, S, Symons, J, Barlow, N L, Normandale, A, Garcha, R, Richter, A G, Faustini, S E, Orton, C, Ford, D, Lyons, R A, Davies, G A, Kee, F, Griffiths, C J, Norrie, J, Sheikh, A, Shaheen, S O, Relton, C & Martineau, A R 2022, ' Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and covid-19: phase 3 randomised controlled trial (CORONAVIT) ', BMJ, vol. 378, e071230 . https://doi.org/10.1136/bmj-2022-071230
ObjectiveTo determine the effect of population level implementation of a test-and-treat approach to correction of suboptimal vitamin D status (25-hydroxyvitamin D (25(OH)D) DesignPhase 3 open label randomised controlled trial.SettingUnited Kingdom.Pa
Autor:
David A. Jolliffe, Hayley Holt, Matthew Greenig, Mohammad Talaei, Natalia Perdek, Paul Pfeffer, Giulia Vivaldi, Sheena Maltby, Jane Symons, Nicola L. Barlow, Alexa Normandale, Rajvinder Garcha, Alex G. Richter, Sian E. Faustini, Christopher Orton, David Ford, Ronan A. Lyons, Gwyneth A. Davies, Frank Kee, Christopher J. Griffiths, John Norrie, Aziz Sheikh, Seif O. Shaheen, Clare Relton, Adrian R. Martineau
OBJECTIVESTo determine whether population-level implementation of a test-and- treat approach to correction of sub-optimal vitamin D status (25-hydroxyvitamin D [25(OH)D] DESIGNPhase 3 open-label randomised controlled trial (CORONAVIT) utilising trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0925d14462beed6a651e0a6fa50c5039
https://doi.org/10.1101/2022.03.22.22271707
https://doi.org/10.1101/2022.03.22.22271707
Autor:
Giulia Vivaldi, David A Jolliffe, Sian Faustini, Hayley Holt, Natalia Perdek, Mohammad Talaei, Florence Tydeman, Emma S Chambers, Weigang Cai, Wenhao Li, Joseph M Gibbons, Corinna Pade, Áine McKnight, Seif O Shaheen, Alex G Richter, Adrian R Martineau
In this population-based cohort of 7530 adults, combined IgG/A/M anti-Spike titres measured after SARS-CoV-2 vaccination were predictive of protection against breakthrough SARS-CoV-2 infection. Discrimination was significantly improved by adjustment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::972e5cdd2d43368299b371a678e590ba
https://doi.org/10.1101/2022.02.11.22270667
https://doi.org/10.1101/2022.02.11.22270667
Autor:
David A Jolliffe, Sian E Faustini, Hayley Holt, Natalia Perdek, Sheena Maltby, Mohammad Talaei, Matthew Greenig, Giulia Vivaldi, Florence Tydeman, Jane Symons, Gwyneth A Davies, Ronan A Lyons, Christopher J Griffiths, Frank Kee, Aziz Sheikh, Seif O Shaheen, Alex G Richter, Adrian R Martineau
Publikováno v:
SSRN Electronic Journal.
SummaryBackgroundAntibody responses to SARS-CoV-2 vaccination vary for reasons that remain poorly understood.MethodsWe tested for presence of combined IgG, IgA and IgM (IgGAM) anti-spike antibodies before and after administration of two doses of ChAd
Autor:
Mohammad Talaei, Sian Faustini, Hayley Holt, David A. Jolliffe, Giulia Vivaldi, Matthew Greenig, Natalia Perdek, Sheena Maltby, Carola M Bigogno, Jane Symons, Gwyneth A Davies, Ronan A Lyons, Christopher J Griffiths, Frank Kee, Aziz Sheikh, Alex G Richter, Seif O Shaheen, Adrian R Martineau
Publikováno v:
Talaei, M, Faustini, S, Holt, H, Jolliffe, D A, Vivaldi, G, Greenig, M, Perdek, N, Maltby, S, Bigogno, C M, Symons, J, Davies, G A, Lyons, R A, Griffiths, C J, Kee, F, Sheikh, A, Richter, A G, Shaheen, S O & Martineau, A R 2022, ' Determinants of pre-vaccination antibody responses to SARS-CoV-2: a population-based longitudinal study (COVIDENCE UK) ', BMC Medicine, vol. 20, 87 . https://doi.org/10.1186/s12916-022-02286-4
Talaei, M, Faustini, S, Holt, H, Jolliffe, D A, Vivaldi, G, Greenig, M, Perdek, N, Maltby, S, Bigogno, C M, Symons, J, Davies, G A, Lyons, R A, Griffiths, C J, Kee, F, Sheikh, A, Richter, A G, Shaheen, S O & Martineau, A R 2022, ' Determinants of pre-vaccination antibody responses to SARS-CoV-2: a population-based longitudinal study (COVIDENCE UK) ', BMC Medicine, vol. 20, no. 1, 87 . https://doi.org/10.1186/s12916-022-02286-4
Talaei, M, Faustini, S, Holt, H, Jolliffe, D A, Vivaldi, G, Greenig, M, Perdek, N, Maltby, S, Bigogno, C M, Symons, J, Davies, G A, Lyons, R A, Griffiths, C J, Kee, F, Sheikh, A, Richter, A G, Shaheen, S O & Martineau, A R 2022, ' Determinants of pre-vaccination antibody responses to SARS-CoV-2: a population-based longitudinal study (COVIDENCE UK) ', BMC Medicine, vol. 20, no. 1, 87 . https://doi.org/10.1186/s12916-022-02286-4
BackgroundProspective population-based studies investigating multiple determinants of pre-vaccination antibody responses to SARS-CoV-2 are lacking.MethodsWe did a prospective population-based study in SARS-CoV-2 vaccine-naive UK adults recruited betw
Autor:
Alex G. Richter, Hayley Holt, Sheena Maltby, Mohammad Talaei, Natalia Perdek, Frank Kee, Adrian R. Martineau, Giulia Vivaldi, Jane Symons, Sian E Faustini, Chris Griffiths, Gwyneth A. Davies, David A. Jolliffe, Seif O. Shaheen, Ronan A Lyons, Aziz Sheikh, Matthew Greenig
Publikováno v:
SSRN Electronic Journal.
Background: Prospective population-based studies investigating multiple determinants of pre-vaccination antibody responses to SARS-CoV-2 are lacking. Methods: We did a prospective population-based study in SARS-CoV-2 vaccine-naive UK adults between M